Guardant Health Equity 2024

Guardant Health Aktienanalyse

What does Guardant Health do?

Guardant Health Inc is an American company specializing in the development of non-invasive diagnostic tests for cancer. The company was founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz. The two founders had previously successfully founded a company specialized in the development of blood tests for pregnancies. Guardant Health's goal is to detect traces of cancer cells in the blood of patients to enable early cancer diagnosis. Based on the liquid biopsy tests offered by the company, doctors can identify tumor cells and genetic mutations without relying on invasive methods such as tissue sampling. This allows for faster diagnosis and quicker treatment decision-making. Guardant Health's business model is based on the commercialization of its liquid biopsy tests, which are based on specially developed DNA sequencing methods. The company offers both diagnostic tests that can aid in cancer identification, as well as tests that can help doctors monitor the success of cancer therapies. Guardant Health has directed its offerings towards multiple products and divisions, including Guardant360, GuardantOmni, and GuardantReveal. Each of these products aims to solve specific challenges related to cancer diagnosis and treatment. Guardant360 is a diagnostic test specifically developed to help doctors sequence the DNA of cancer cells in the blood of patients and identify the genetic changes contributing to tumor growth. On the other hand, GuardantOmni is a liquid biopsy test that targets a broader range of cancer types. It enables a comprehensive genetic scan of cancer cells in the blood to identify specific mutations that can aid in tracking disease progression and selecting appropriate therapies. GuardantReveal is a test aimed at monitoring patients at higher risk of cancer. The test can be used to detect early signs of tumors in patients who are at higher risk due to their family history, age, or other factors. Guardant Health has achieved considerable success in the field of liquid biopsy detection in recent years. Currently, more than 100,000 patients worldwide have access to Guardant Health's liquid biopsy-based tests. The company is based in Redwood City, California, and employs over 1,000 employees. It has a broad investor base, including The SoftBank Vision Fund, Sequoia Capital, Lightspeed Venture Partners, and Khosla Ventures. Overall, the company has raised over $550 million in funding. Guardant Health aims to revolutionize the world of cancer diagnostics and treatment. By radically changing the process of diagnosing and monitoring cancer patients, the company aims to improve the survival rate of cancer patients and make cancer treatment more effective overall. Guardant Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Guardant Health's Equity

Guardant Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Guardant Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Guardant Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Guardant Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Guardant Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Guardant Health stock

What is the equity of Guardant Health this year?

Guardant Health has equity of 158.68 M USD this year.

What was the equity of Guardant Health compared to the previous year?

The equity of Guardant Health has increased/decreased by 163.59% increased compared to the previous year.

What impact does a high equity have on investors of Guardant Health?

A high equity is advantageous for investors of Guardant Health as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Guardant Health?

A low equity can be a risk for investors of Guardant Health, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Guardant Health affect the company?

An increase in equity of Guardant Health can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Guardant Health affect the company?

A reduction in equity of Guardant Health can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Guardant Health?

Some factors that can affect the equity of Guardant Health include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Guardant Health so important for investors?

The equity of Guardant Health is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Guardant Health take to change the equity?

To change equity, Guardant Health can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Guardant Health pay?

Over the past 12 months, Guardant Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Guardant Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Guardant Health?

The current dividend yield of Guardant Health is .

When does Guardant Health pay dividends?

Guardant Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Guardant Health?

Guardant Health paid dividends every year for the past 0 years.

What is the dividend of Guardant Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Guardant Health located?

Guardant Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Guardant Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Guardant Health from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Guardant Health pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Guardant Health in the year 2023?

In the year 2023, Guardant Health distributed 0 USD as dividends.

In which currency does Guardant Health pay out the dividend?

The dividends of Guardant Health are distributed in USD.